Adhering to the current guideline standard for intraoperative nodal assessment in resected non–small cell lung cancer (NSCLC) ...
The clinical datasets presented at ASCO 2026 by CStone further validate the trispecific synergistic mechanism of CS2009 and support its potential to become a next-generation immuno-oncology (I/O) ...
Adding apalutamide to ADT in the adjuvant and neoadjuvant settings improves outcomes in prostate cancer patients undergoing ...
The first female tenure-track professor hired at Johns Hopkins in the physical sciences, Huang led discoveries into ...
The treatment landscape for these patients is evolving ...
Despite being more commonly diagnosed in women ages 40 or younger, an estimated 10% to 15% of early triple-negative breast cancer (TNBC) cases are diagnosed in patients over 70. Current guidelines ...
The MOTheR and CONCORDIA studies show HDx therapy (expanded hemodialysis) enabled by the Theranova dialyzer delivers outcomes comparable to ...
Key Points Interested in Arvinas, Inc.? Here are five stocks we like better. Arvinas is narrowing its pipeline focus after the first PROTAC approval, concentrating internal investment on ...
Lymph node sampling with the 3 + 1 rule was not associated with increased postoperative complications after lung cancer ...
Food Coloring Additives and Incidence of Type 2 Diabetes in the NutriNet-Santé Prospective Cohort 1. Several widely consumed ...
GLP-1 RA exposure reduced incident HR+/HER2– breast cancer at 36 months (RR 0.88) and improved overall survival across age strata (overall HR 0.75) in BMI 25–35, nondiabetic women. Datopotamab ...
(UroToday.com) The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting was host to State-of-the-Art Session on advances in the perioperative management of bladder and kidney cancers. Dr.